[go: up one dir, main page]

CL2007001468A1 - Uso de uno o varios agentes antiepilepticos o anticonvulsivantes y de un compuesto derivado de benzoheteroaril-sulfamida para tratar epilepsia o un trastorno relacionado. - Google Patents

Uso de uno o varios agentes antiepilepticos o anticonvulsivantes y de un compuesto derivado de benzoheteroaril-sulfamida para tratar epilepsia o un trastorno relacionado.

Info

Publication number
CL2007001468A1
CL2007001468A1 CL200701468A CL2007001468A CL2007001468A1 CL 2007001468 A1 CL2007001468 A1 CL 2007001468A1 CL 200701468 A CL200701468 A CL 200701468A CL 2007001468 A CL2007001468 A CL 2007001468A CL 2007001468 A1 CL2007001468 A1 CL 2007001468A1
Authority
CL
Chile
Prior art keywords
benzoheteroaril
sulfamide
antiepileptic
miscellaneous
related disorder
Prior art date
Application number
CL200701468A
Other languages
English (en)
Inventor
Virginia L Par Smith-Swintosky
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of CL2007001468A1 publication Critical patent/CL2007001468A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A61K31/381—Heterocyclic compounds having sulfur as a ring hetero atom having five-membered rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
CL200701468A 2006-05-19 2007-05-22 Uso de uno o varios agentes antiepilepticos o anticonvulsivantes y de un compuesto derivado de benzoheteroaril-sulfamida para tratar epilepsia o un trastorno relacionado. CL2007001468A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US80200106P 2006-05-19 2006-05-19

Publications (1)

Publication Number Publication Date
CL2007001468A1 true CL2007001468A1 (es) 2008-04-04

Family

ID=38510389

Family Applications (1)

Application Number Title Priority Date Filing Date
CL200701468A CL2007001468A1 (es) 2006-05-19 2007-05-22 Uso de uno o varios agentes antiepilepticos o anticonvulsivantes y de un compuesto derivado de benzoheteroaril-sulfamida para tratar epilepsia o un trastorno relacionado.

Country Status (7)

Country Link
US (1) US20070293476A1 (es)
AR (1) AR061066A1 (es)
CL (1) CL2007001468A1 (es)
PE (1) PE20080234A1 (es)
TW (1) TW200812574A (es)
UY (1) UY30360A1 (es)
WO (1) WO2007137164A2 (es)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11660275B2 (en) 2018-03-20 2023-05-30 Eisai R&D Management Co., Ltd. Epilepsy treatment agent

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY147767A (en) * 2004-06-16 2013-01-31 Janssen Pharmaceutica Nv Novel sulfamate and sulfamide derivatives useful for the treatment of epilepsy and related disorders
AR049646A1 (es) * 2004-06-16 2006-08-23 Janssen Pharmaceutica Nv Derivados de sulfamato y sulfamida utiles para el tratamiento de la epilepsia y trastornos relacionados
AU2006249577A1 (en) * 2005-05-20 2006-11-30 Janssen Pharmaceutica N.V. Process for preparation of sulfamide derivatives
US8691867B2 (en) * 2005-12-19 2014-04-08 Janssen Pharmaceutica Nv Use of benzo-fused heterocycle sulfamide derivatives for the treatment of substance abuse and addiction
US8716231B2 (en) * 2005-12-19 2014-05-06 Janssen Pharmaceutica Nv Use of benzo-fused heterocycle sulfamide derivatives for the treatment of pain
US8937096B2 (en) * 2005-12-19 2015-01-20 Janssen Pharmaceutica Nv Use of benzo-fused heterocyle sulfamide derivatives for the treatment of mania and bipolar disorder
US20070155823A1 (en) * 2005-12-19 2007-07-05 Smith-Swintosky Virginia L Use of benzo-fused heterocycle sulfamide derivatives as neuroprotective agents
US20070155827A1 (en) * 2005-12-19 2007-07-05 Smith-Swintosky Virginia L Use of benzo-fused heterocycle sulfamide derivatives for the treatment of depression
US8497298B2 (en) * 2005-12-19 2013-07-30 Janssen Pharmaceutica Nv Use of benzo-fused heterocycle sulfamide derivatives for lowering lipids and lowering blood glucose levels
AR058389A1 (es) * 2005-12-19 2008-01-30 Janssen Pharmaceutica Nv Uso de derivados heterociclicos benzo-fusionados de sulfamida para el tratamiento de la obesidad
US20070191474A1 (en) * 2006-02-15 2007-08-16 Smith-Swintosky Virginia L Use of benzo-fused heterocyle sulfamide derivatives for the treatment of migraine
AU2007253814A1 (en) * 2006-05-19 2007-11-29 Janssen Pharmaceutica N.V. Co-therapy for the treatment of epilepsy
EP2992891B1 (en) 2006-06-15 2020-08-05 UCB Pharma GmbH Pharmaceutical composition comprising brivaracetam and lacosamide with synergistic anticonvulsant effect
US20090247617A1 (en) * 2008-03-26 2009-10-01 Abdel-Magid Ahmed F Process for the preparation of benzo-fused heteroaryl sulfamates
US20090247616A1 (en) * 2008-03-26 2009-10-01 Smith-Swintosky Virginia L Use of benzo-fused heterocyle sulfamide derivatives for the treatment of anxiety
EA018567B1 (ru) 2008-06-23 2013-08-30 Янссен Фармацевтика Нв Кристаллическая форма (2s)-(-)-n-(6-хлор-2,3-дигидробензо[1,4]диоксин-2-илметил)сульфамида
US8815939B2 (en) * 2008-07-22 2014-08-26 Janssen Pharmaceutica Nv Substituted sulfamide derivatives
US8609849B1 (en) 2010-11-30 2013-12-17 Fox Chase Chemical Diversity Center, Inc. Hydroxylated sulfamides exhibiting neuroprotective action and their method of use
US8652527B1 (en) 2013-03-13 2014-02-18 Upsher-Smith Laboratories, Inc Extended-release topiramate capsules
US9101545B2 (en) 2013-03-15 2015-08-11 Upsher-Smith Laboratories, Inc. Extended-release topiramate capsules
CA2961410C (en) 2014-09-16 2023-07-11 India Globalization Capital, Inc. Cannabinoid composition and method for treating pain
HK1247096A1 (zh) 2015-01-25 2018-09-21 India Globalization Capital, Inc. 治疗痉挛疾病的组合物和方法
WO2017027651A1 (en) 2015-08-12 2017-02-16 India Globalization Capital, Inc. Method and composition for treating cachexia and eating disorders
WO2017218629A1 (en) 2016-06-15 2017-12-21 India Globalization Capital, Inc. Method and composition for treating seizure disorders
WO2024054807A1 (en) * 2022-09-06 2024-03-14 Biohaven Therapeutics Ltd. Combination therapies including metal channel activators and tdp-43 modulators

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4513006A (en) * 1983-09-26 1985-04-23 Mcneil Lab., Inc. Anticonvulsant sulfamate derivatives
AU1328197A (en) * 1995-12-01 1997-06-19 Synaptic Pharmaceutical Corporation Aryl sulfonamide and sulfamide derivatives and uses thereof
MXPA02001820A (es) * 1999-08-20 2003-07-14 Johnson & Johnson Composicion que comprende un material de tramadol y un farmaco anticonvulsivo.
CN1897950A (zh) * 2003-10-14 2007-01-17 惠氏公司 稠合芳基和杂芳基衍生物及其使用方法
US20050245460A1 (en) * 2004-02-13 2005-11-03 Meyerson Laurence R Methods and compositions for the treatment of epilepsy, seizure disorders, and other CNS disorders
US20060047001A1 (en) * 2004-08-24 2006-03-02 Parker Michael H Novel benzo-fused heteroaryl sulfamide derivatives useful as anticonvulsant agents
US20070191460A1 (en) * 2006-02-15 2007-08-16 Smith-Swintosky Virginia L Use of Benzo-Heteroaryl Sulfamide Derivatives for the Treatment of Disease Modification / Epileptogenesis

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11660275B2 (en) 2018-03-20 2023-05-30 Eisai R&D Management Co., Ltd. Epilepsy treatment agent

Also Published As

Publication number Publication date
WO2007137164A3 (en) 2008-01-17
US20070293476A1 (en) 2007-12-20
AR061066A1 (es) 2008-07-30
WO2007137164A2 (en) 2007-11-29
TW200812574A (en) 2008-03-16
PE20080234A1 (es) 2008-04-25
UY30360A1 (es) 2007-08-31

Similar Documents

Publication Publication Date Title
CL2007001468A1 (es) Uso de uno o varios agentes antiepilepticos o anticonvulsivantes y de un compuesto derivado de benzoheteroaril-sulfamida para tratar epilepsia o un trastorno relacionado.
CL2007001467A1 (es) Uso de agentes antiepilepticos o anticonvulsivantes y un compuesto derivado de heterociclil-alquil-sulfamida para tratar la epilepsia o un trastorno relacionado.
EP2315220A4 (en) REACTOR COMPONENT AND REACTOR
FR2938767B1 (fr) Composition photoprotectrice contenant un amidon gelifiant et des particules de polyamide
EP2199420A4 (en) AUSTENITIC STAINLESS STEEL
EP2199419A4 (en) AUSTENITIC STAINLESS STEEL
EP1990437A4 (en) CORROSION RESISTANT STEEL MATERIAL FOR A BOAT AND A BUILDING
EP2060644A4 (en) MARTENSITIC STAINLESS STEEL
EP2681849A4 (en) SYSTEMS AND METHOD FOR SELECTIVELY EXCLUDING TONES FROM A VECTORING
EP2280090A4 (en) FERRITIC STAINLESS STEEL
CL2014000366A1 (es) Composicion resistente a la contaminacion que comprende un elastomero y un componente seleccionado de lanolina acilada, lanolina alcoxilada o aceite de lanolina; metodo; uso de la composicion; y sustrato.
ES2349082T8 (es) Endurecimiento de un líquido.
EP2092038A4 (en) Scale squeeze treatment systems and methods
BR112012018986A2 (pt) sistemas e métodos para redução de lodos produzidos por estações de tratamento de águas residuais
EP2334226A4 (en) COGNITION AND LINGUISTIC TESTING BY EYE TRIAL
BRPI0924425A2 (pt) "combinações de substâncias ativas sinergéticas".
IL219143A0 (en) Lean austenitic stainless steel
EP2510097A4 (en) ANTIMICROBIAL ACTIVE FROM PAENIBACILLUS SP. AND METHOD AND ITS USES
DE602008004719D1 (de) Schnelles Sensorsystem und -verfahren für durch aufgehäufte Erde oder Bordsteine ausgelöste Fahrzeugüberschläge
EP2453381A4 (en) SYSTEM FOR PREDICTING CYBER ATTACKS AND METHOD FOR PREDICTING CYBER ATTACKS USING THIS SYSTEM
BRPI0921203A2 (pt) monitoramento de ureia e programação de reabastecimento de veículos
BRPI0916744A2 (pt) filtro de fluxo direto e método para fazer o mesmo
BRPI0811470A2 (pt) Paralelização de estruturas sequenciais usando transações.
BRPI1012765A2 (pt) sistemas e método de coleta de algas.
FR2939728B1 (fr) Agencement d'un composant et d'un element d'actionnement associe a ce composant.